Our research expands the genotypic and phenotypic spectrum of TP73 mutations in the ALS-FTD spectrum, adding to our current understanding of the characteristic clinical phenotype of ALS patients carrying rare pathogenic TP73 variants. This evidence concerns the gene TP73 and amyotrophic lateral sclerosis.